Chemical formula: C₂₇H₃₅N₆O₈P Molecular mass: 602.585 g/mol
Remdesivir is indicated for:
Population group: only minors (0 - 18 years old) , adults (18 years old or older)
Remdesivir is indicated for the treatment of coronavirus disease 2019 (COVID-19) in adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other noninvasive ventilation at start of treatment).
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)
Remdesivir is indicated for the treatment of coronavirus disease 2019 (COVID-19) in adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Remdesivir is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.